Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study
NCT: NCT07324031 · RECRUITING
Brief Summary
The ALARION EV Study is a prospective, multi-center, single-arm, non-randomized study without concurrent or historical controls. The purpose of this pivotal study is to generate evidence of safety and effectiveness to apply for regulatory approvals for commercialization of the Parasternal EV-ICD System. The objective of the study is to demonstrate safety and effectiveness of the Parasternal EV-ICD System through 6-months.
Frequently Asked Questions
What is Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study?
Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study is a clinical trial registered under NCT07324031. Current status: RECRUITING.
What is the status of NCT07324031?
The current status of NCT07324031 (Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study) is: RECRUITING.
When did Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study start?
Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study started on 2026-07-02.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.